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Editorial Note: Special Edition
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a b s t r a c t
This special issue contains four review articles that analyze the development and biology
of innate lymphoid cells (ILCs), which are the most recently-discovered group of innate
immune cells. This unique group of lymphoid cells lacks the RAG gene and consequently
does not express B cell nor T cell antigen-specific receptors. They are abundant at mucosal
surfaces, where they play a role in immunity and homeostasis. The ILCs are the focus of
intensive research efforts to understand their development and function.
This special issue contains four review articles by experts in
the emerging field of innate lymphoid cell (ILC) development
and biology.
The first review, by Dr. Tsukasa Nabekura and Dr. Akira
Shibuya [1], describes common features of Nature Killer (NK)
cells and a subset of ILCs, ILC1, such as their requirement for
T-bet transcription factor for maturation, secretion of high
quantities of IFN-g, dependence on IL-15 for development,
and expression of specific cytokine receptors. They also
summarize the differences between NK cells and ILC1s. NK
cells exhibit powerful cytotoxic activity and migrate in
lymphatic and blood vessels, while ILC1s are not cytotoxic
and are mainly tissue-resident. In the second part of their
review, the authors analyze the role of ILC1s in liver, in-
testines, adipose tissues and several other tissues such as
salivary glands, kidney, skin and lung. In the liver, after
infection with mouse cytomegalovirus or during drug-
induced acute liver injury, conventional type 1 dendritic
cells release large amounts of IL-12, which stimulates ILC1s
to produce IFN-g. This limits the replication of the virus in
the liver and confers resistance to viral infection. In drug-
induced acute liver injury, ILC1s are the first cells to be
activated among several lymphocyte subsets and have a
protective effect on injured hepatocytes by producing INF-g,
increasing expression of the anti-apoptotic protein Bcl-xL.
The authors also summarize studies that established the
major role of intestinal ILC1s against bacteria and parasites
through the rapid production of IFN-g. Interestingly, ILC1s
have a complex role during the development of obesity and
contribute to the establishment of an inflammatory envi-
ronment in adipose tissues, resulting in glucose intolerance
and insulin resistance. Finally, the authors discuss studies
that show that ILC1s can proliferate and differentiate into
long-lived cells that produce increased IFN-g in response to
specific antigens such as mouse cytomegalovirus. Overall,
this interesting review shows that tissue-resident ILC1s can
protect the host against bacteria or parasites by rapidly
producing large amounts of IFN-g; but they also control local
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inflammation, modulate tissue lesions, and maintain
homeostasis.
The second article, by Dr. Serge van de Pavert [2], ana-
lyzes the role of Lymphoid Tissue Inducer (LTI) cells, which
are members of the ILC family, in the formation of lymph
nodes (LN). In the first part of this review, the ontogeny of
LTi is described. The author presents evidence that mouse
LTi progenitors appear around embryonic day 8 (E8.5) and
derive from embryonic hemogenic sources: the embryonic
vitelline artery or the aorta-gonad-mesonephros. Embryonic
LTi cells implicated in LN formation are replaced by bone-
marrow hematopoietic stem cells derived LTi cells in adult
mice. In fetal liver (FL), the common lymphoid precursors
differentiate and generate LTi precursor cells that have left
the FL to colonize the LN anlagen. In this tissue, the
expression of the retinoic acid-receptor-related orphan nu-
clear receptor gamma (RORgt) triggers LTi commitment and
differentiation of LTi precursors into LTi0 and mature LTi4
cells. Two sections of this review describe and analyze the
complex role of LTi cells in embryonic LN [Fig. 1] and of ILC3
and LTi-like cells in adult LNs and gut. This comprehensive
review, written by an expert in the field, should help readers
understand how LTi cells contribute to the formation of LNs
in embryos and adults.
The third review, by Dr. Rachel Golub [3], summarizes the
current state of knowledge about the role of Notch signaling
pathways in fetal and adult ILC development and differenti-
ation. The Notch signaling pathway and the methods used to
study this pathway are presented in the first section, followed
by a description of the role of Notch in ILC development.While
Notch1 is involved in T lymphocyte development, only Notch2
transcripts are expressed in lymphoid precursors of ILC, with
expression of Id2 and CXCR6 correlating with ILC commit-
ment. Interestingly, Notch2 signaling is not required for early
stages of fetal ILC lineage commitment. In addition, Notch
signaling is dispensable for fetal LTi development, whereas it
is required for ILC3 differentiation. Finally, Notch is required
for normal ILC3 differentiation but not for LTi. A separate
section of the review shows how Notch signaling maintains
an equilibrium among the heterogeneous subsets of ILC3 in
the adult small intestine. The last part of this review is
devoted to the complex topic of Notch signaling pathways in
regulation of ILC function. It has been established that Notch
signaling is involved in the acquisition of Th17 inflammatory
function by ILC2s. These KLRG2hi ILC2s, defined as inflam-
matory ILC2s (iILC2s), express GATA3 (a key transcription
factor of ILC2) but also high levels of Dtx1 and low levels of
Rorgt (a key transcription factor of ILC3), allowing the same
Fig. 1 Earliest phases in lymph node formation. (1) Retinoic acid induces expression of (2) CXCL13 by mesenchymal cells, which
(3) attracts LTiP and LTi cells from the blood. (4) RANK-L expressed on LTi cells and mesenchymal cells interacts with RANK on
the LTi cells, leading to (5) lymphotoxin-a1b2 (LTa1b2) expression on LTi4 cells. (6) Interaction of LTi4 cells with lymphotoxin-b
receptor (LTbR)-expressing stromal cells results in differentiation into stromal organizer cells. (7) After lymphotoxin signaling,
lymphatic endothelial cells migrate to the lymph node anlagen. Source: van de Pavert [2].
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cell to share biological functions of ILC2 and ILC3. Blocking
Notch1 and/or Notch2 in vivo demonstrated that iILC2 plas-
ticity is dependent on both Notch1 and Notch2. This section
also analyzes the complex mechanisms potentially controlled
by Notch signaling to modulate the abundance of ILCs in
different tissues and to regulate their function.
The last article, by Dr. Jean-Charles Guery and colleagues
[4], analyzes the role of sex steroid hormones on group 2 ILC
development and tissue-specific immunity. In the first part of
this review, the authors describe the development of ILCs and
NK cells from common lymphoid precursors. They then briefly
discuss ILC function in homeostatic and pathophysiological
situations. In the second section of this article, the authors
introduce the basics of estrogen and androgen receptor
signaling pathways; they analyze studies showing that ILC2
express high levels of androgen receptor; and they discuss the
expression of co-regulators of androgen receptor like chap-
erone proteins or pioneer factors, which are known to enhance
androgen receptor action. In the third section of this review,
they discuss evidence that ILC2s are differentially regulated in
males and females and that androgen-receptor signaling in
ILC2s inhibits IL-33-driven ILC2 expansion in males. They also
describe experiments from their own laboratory demon-
strating that 5a-dihydrotestosterone or selective androgen re-
ceptor modulators (SARMs) trigger the development and
differentiation of CD90dull ILC2s in vitro, of which 40% express
the KLRG1 molecule. In contrast, the androgen receptor
antagonist Flutamide promotes the development of CD90hi
KLRGneg ILC2s, which are similar to the tissue-resident lung
ILC2s found in female mice. Experimental evidence suggests
thatmale ILC2s produce less IL-5 and IL-13 after stimulation by
IL-2 and IL-33. Finally, ILC2s can increase airway inflammation
through IL-5 and IL-13 production, and these cells can promote
lung homeostasis because IL-13 triggers epithelial cell survival.
In addition, ILC2s release amphiregulin, which contributes to
the regeneration of the bronchial epithelium.
These results suggest that androgen signaling decreases
the development of ILC2s in lungs, explaining the weaker
airway inflammation observed in male mice when compared
to females, and they correlate with the observations that
asthma is more frequent in women than in men. In addition,
the number of circulating ILC2s in asthmatic men is signifi-
cantly lower than in women patients. Thus, SARMs, which
stimulate androgen receptors of ILC2s and decrease ILC2
abundance in lungs, should be considered as targets for
treatment of allergic asthma.
Taken together, these four articles provide the reader with
an overview of the rapidly expanding literature on ILC devel-
opment, and suggest clinical applications that can already be
envisioned based on our understanding of ILC biology.
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